J&J and Merck Ebola Vaccines Produce Lasting Antibodies in Children and Adults: Studies

Ebola vaccines developed by Johnson & Johnson and Merck produced virus-fighting antibodies and appear to be safe in children and adults, according to data from two studies published on Wednesday.
Reuters Health Information

source https://www.medscape.com/viewarticle/985600?src=rss